News

AMT and Amgen claim that the GDNF gene contains the information to produce a protein necessary for the development and survival of nerve cells. According to AMT, the

Specifically, the Therapex Division of E-Z-EM Canada, a wholly-owned subsidiary of Bracco Pharma in Italy, will manufacture the product for Apricus Bio. Apricus said Therapex will also be

Nanjing MeiRui is the operating entity of Pagoda Pharma Group, a British Virgin Islands-based holding company that established the Chinese health-care company in 1996. Branded drugmakers, including GSK,

The UK drug maker acquired SRT501, a proprietary formulation of resveratrol, a substance found in grapes and red wine, from biotech company Sirtris Pharmaceuticals, as part of the

Ezogabine is an investigational anti-epileptic drug being studied for the adjunctive treatment of adults with partial-onset seizures. A CRL is issued by the FDA’s Center for Drug Evaluation

The transaction, latest in a series of biotech deals by major drug firms facing the prospect of patent cliff for their blockbuster drugs, will exceed $500m if several

ella was approved by the US Food and Drug Administration (FDA) as safe and effective in helping to prevent unintended pregnancy for up to five days after unprotected

The grant has been made to defer some of the company’s research expenditures related to the development of its novel and patented technology, CollaFix, as a drug delivery

The BioClinica Certified Partner (BCP) Program helps CROs address many of the complexities associated with clinical trials by leveraging the focus and the power of BioClinica software and